• Proceedings of the Korean Society of Crop Science Conference
• /
• 2006.11a
• /
• pp.33.2-33.2
• /
• 2006

• Proceedings of the Korean Society of Crop Science Conference
• /
• 2006.04a
• /
• pp.128-129
• /
• 2006

• Proceedings of the Korea Environmental Mutagen Society Conference
• /
• 2004.11a
• /
• pp.151-152
• /
• 2004

• Journal of Embryo Transfer
• /
• v.33 no.1
• /
• pp.13-16
• /
• 2018

We observed the external genitalia and uterus of a 24-month-old freemartin Hanwoo. The vulva was smaller than observed in a normal female Hanwoo, while the clitoris was larger in the freemartin. The angle between the external genitalia and the perineum also varied. Upon internal genital examination, the uterus of the freemartin was a thin tube approximately 18 cm in size and had not differentiated into a normal uterus and uterine horns.

• Proceedings of the PSK Conference
• /
• 2002.04a
• /
• pp.207.3-208
• /
• 2002

• The Plant Pathology Journal
• /
• v.21 no.4
• /
• pp.377-382
• /
• 2005

Infection rate of Chrysanthemum stunt viroid (CSVd) in 64 commercial chrysanthemum cultivars cultivated in Korea ranged from 9.7 to 66.8$\%$. Symptoms on leaves of CSVd-infected chrysanthemum included yellow spots, chlorosis, vein clearing, vein bending and crumpling. CSVd induced flower malformation in 'Scot', color change in 'Sharotte', and color breaking in 'Sharon'. CSVd caused reduction of plant height, leaf size, flower size and the flowers number by $32-50\%,\;26-35\%$, $14-36\%\;and\;14-75\%$, respectively. In conclusion, CSVd affected plant height, leaf size and flower quality in chrysanthemum plants.

• Korean Journal of Organic Agriculture
• /
• v.19 no.spc
• /
• pp.1-5
• /
• 2011

A new powdery mildew resistant squash (Cucurbita moschata Duch.) 'Miso' was bred from a cross between powdery mildew resistant true variety 'Sangol' and powdery mildew susceptible inbred line 'Seoulmadi' at National Institute of Horticultural & Herbal Science (NIHHS). The 'Miso' variety was vigorous and highly resistant to powdery mildew. It showed white green fruit color. The variety yielded 21.3MT/ha which is 52% more than control variety.

• Asian Journal of Innovation and Policy
• /
• v.11 no.2
• /
• pp.148-182
• /
• 2022

This study analyzed changes in the national research facilities & equipment (RFE) policies historically promoted by the Rho administration (2003~2007), Lee administration (2008~2012), Park administration (2013~2016), and Moon administration (2017~2019) in South Korea. By adding new variables such as policy goals and policy means to a model suggested by Hogwood and Peters (1983), policy change types and their flow could be better classified. Korean RFE policies showed various flows in the policy change types instead of a general flow, which is the order of policy innovation -> policy innovation -> policy succession -> policy succession. This finding indicates that each administration could pursue a higher-level policy change purposively. It is highly required to prepare policy development that devotes to organizing and operating a national council, reflecting in the government's comprehensive plan after evaluating policy effectiveness, improving items needed for the RFE status survey, and unifying the research equipment registration.

• YAKHAK HOEJI
• /
• v.55 no.4
• /
• pp.345-351
• /
• 2011

Gastritis is the most common disease among Korean. The demand for the development of gastritis drugs has been increasing. Currently, however, there is no guideline available for the clinical evaluation of gastritis drugs worldwide. As a consequence, domestic and international pharmaceutical companies make errors in the drug development processes, and it becomes difficult for them to establish the scientific validity and objectivity of newly developed drugs. The objective of this study was to develop the Guideline for Clinical Trials Evaluation of Gastritis which can be used in improving the quality and consistency of clinical trials. First, we collected and reviewed the clinical trials on gastritis drugs that were available from Japan Pharmaceuticals and Medical Devices Agency and Korea Food and Drug Administration (KFDA), and investigated the recent research trends on clinical trials of gastritis drugs. Reviewers from KFDA and National Institute of Food and Drug Safety Evaluation and scientific experts from the pharmaceutical industries developed the guidelines through regularly scheduled meetings. Opinions and consultation from academic fields and industry experts were also obtained. This project will provide the clinical trial practitioners, investigator and reviewers the scientific and rational guidelines for performance and evaluation of clinical trials for gastritis drugs. Furthermore, we hope this guideline contributes to establishing the national competitiveness, improving the quality of clinical trial, and encouraging researches on drug development for gastritis.

• Asian Pacific Journal of Cancer Prevention
• /
• v.16 no.5
• /
• pp.1699-1705
• /
• 2015

Background: Medication errors in oncology may cause severe clinical problems due to low therapeutic indices and high toxicity of chemotherapeutic agents. We aimed to investigate unintentional medication errors and underlying factors during chemotherapy preparation and administration based on a systematic survey conducted to reflect oncology nurses experience. Materials and Methods: This study was conducted in 18 adult chemotherapy units with volunteer participation of 206 nurses. A survey developed by primary investigators and medication errors (MAEs) defined preventable errors during prescription of medication, ordering, preparation or administration. The survey consisted of 4 parts: demographic features of nurses; workload of chemotherapy units; errors and their estimated monthly number during chemotherapy preparation and administration; and evaluation of the possible factors responsible from ME. The survey was conducted by face to face interview and data analyses were performed with descriptive statistics. Chi-square or Fisher exact tests were used for a comparative analysis of categorical data. Results: Some 83.4% of the 210 nurses reported one or more than one error during chemotherapy preparation and administration. Prescribing or ordering wrong doses by physicians (65.7%) and noncompliance with administration sequences during chemotherapy administration (50.5%) were the most common errors. The most common estimated average monthly error was not following the administration sequence of the chemotherapeutic agents (4.1 times/month, range 1-20). The most important underlying reasons for medication errors were heavy workload (49.7%) and insufficient number of staff (36.5%). Conclusions: Our findings suggest that the probability of medication error is very high during chemotherapy preparation and administration, the most common involving prescribing and ordering errors. Further studies must address the strategies to minimize medication error in chemotherapy receiving patients, determine sufficient protective measures and establishing multistep control mechanisms.